Brian T Hill Selected Research

Vincristine (Oncovin)

1/2023	A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
1/2020	Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
6/2011	Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian T Hill Research Topics

Disease

25	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 01/2016
25	Neoplasms (Cancer) 02/2024 - 09/2011
23	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 09/2011
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 03/2011
17	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 06/2011
16	Lymphoma (Lymphomas) 11/2023 - 10/2013
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2023 - 01/2016
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 10/2013
6	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 09/2007
4	Tumor Lysis Syndrome 10/2023 - 11/2017
4	Disease Progression 01/2023 - 01/2020
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 04/2010
4	Leukemia 12/2021 - 12/2017
2	Hairy Cell Leukemia 05/2022 - 12/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 05/2017
2	Body Weight (Weight, Body) 01/2020 - 12/2017
2	Multiple Myeloma 01/2019 - 01/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 02/2015
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 11/2017
1	Hypertension (High Blood Pressure) 02/2024
1	Diarrhea 10/2023
1	Residual Neoplasm 01/2023
1	Cytokine Release Syndrome 10/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Brain Diseases (Brain Disorder) 04/2021
1	Progressive Multifocal Leukoencephalopathy 04/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 11/2020
1	Chromosome Deletion (Deletion, Chromosome) 01/2019
1	Wound Infection (Wound Infections) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 03/2024 - 01/2016
15	Chimeric Antigen ReceptorsIBA 12/2023 - 12/2017
13	axicabtagene ciloleucelIBA 03/2024 - 12/2017
12	venetoclaxIBA 11/2023 - 07/2015
8	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 01/2016
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 06/2011
5	ibrutinibIBA 02/2024 - 11/2017
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2011
4	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2019
4	brexucabtagene autoleucelIBA 10/2023 - 01/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 06/2011
3	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2019
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 06/2011
3	Busulfan (Busulfex)FDA Link 01/2020 - 01/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 06/2011
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2011
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2016
3	Bortezomib (Velcade)FDA Link 01/2019 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2018 - 07/2015
3	fludarabineIBA 12/2017 - 09/2014
3	idelalisibIBA 11/2017 - 10/2013
2	Lenalidomide (CC 5013)FDA Link 03/2024 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 01/2016
2	Monoclonal AntibodiesIBA 11/2023 - 01/2019
2	ublituximabIBA 10/2023 - 01/2023
2	umbralisibIBA 10/2023 - 01/2023
2	AntibodiesIBA 01/2023 - 01/2016
2	Purine NucleosidesIBA 05/2022 - 12/2017
2	AntigensIBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2021 - 11/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 06/2011
2	purineIBA 12/2017 - 09/2014
2	ABT-737IBA 07/2015 - 09/2011
1	ixazomibIBA 03/2024
1	Antihypertensive Agents (Antihypertensives)IBA 02/2024
1	Alanine Transaminase (SGPT)IBA 01/2024
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 07/2023
1	pembrolizumabIBA 01/2023
1	NivolumabIBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	tisagenlecleucelIBA 01/2023
1	selinexorIBA 04/2021
1	polatuzumab vedotinIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	PlatinumIBA 01/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	HLA-A Antigens (HLA-A)IBA 12/2019
1	HLA-B Antigens (HLA-B)IBA 12/2019
1	Cyclin D1IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	IceIBA 04/2018
1	rasburicase (Elitek)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 01/2018
1	Saline SolutionIBA 01/2018
1	Pentostatin (Nipent)FDA LinkGeneric 12/2017

Therapy/Procedure

44	Therapeutics 03/2024 - 04/2010
13	Cell Transplantation 12/2021 - 02/2015
12	Drug Therapy (Chemotherapy) 02/2024 - 03/2011
9	Stem Cell Transplantation 01/2022 - 09/2007
5	Transplantation 01/2024 - 09/2007
4	Hematopoietic Stem Cell Transplantation 12/2023 - 04/2010
3	Radiotherapy 10/2023 - 04/2016
2	Induction Chemotherapy 10/2023 - 01/2018
2	Immunotherapy 01/2021 - 01/2019
2	Homologous Transplantation 01/2018 - 09/2007
1	Autologous Transplantation 01/2018